Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Valdécoxib")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 79

  • Page / 4
Export

Selection :

  • and

Biotransformation of Valdecoxib by Microbial CulturesSRISAILAM, K; VEERESHAM, C.Journal of microbiology and biotechnology. 2010, Vol 20, Num 4, pp 809-816, issn 1017-7825, 8 p.Article

Le médicament du mois valdécoxib (Bextra®) = Valdecokib (Bextra®)SCHEEN, A. J; MALAISE, M.RMLG. Revue médicale de Liège. 2004, Vol 59, Num 4, pp 251-254, issn 0370-629X, 4 p.Article

Valdecoxib versus rofecoxib in acute postsurgical pain: Results of a randomized controlled trialCHRISTENSEN, Kyle S; CAWKWELL, Gail D.Journal of pain and symptom management. 2004, Vol 27, Num 5, pp 460-470, issn 0885-3924, 11 p.Article

Stability study of amorphous valdecoxibAMBIKE, Anshuman A; MAHADIK, K. R; PARADKAR, Anant et al.International journal of pharmaceutics. 2004, Vol 282, Num 1-2, pp 151-162, issn 0378-5173, 12 p.Article

Pharmacokinetics of intramuscular microparticle depot of valdecoxib in an experimental modelAGNIHOTRI, Sagar M; VAVIA, Pradeep R.Drug development and industrial pharmacy. 2009, Vol 35, Num 9, pp 1043-1047, issn 0363-9045, 5 p.Article

Eudragit S-100 entrapped chitosan microspheres of valdecoxib for colon cancerTHAKRAL, Naveen K; RAY, Alok R; MAJUMDAR, Dipak K et al.Journal of materials science. Materials in medicine. 2010, Vol 21, Num 9, pp 2691-2699, issn 0957-4530, 9 p.Article

Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxibSANCHEZ-BORGES, Mario; CABALLERO-FONSECA, Fernan; CAPRILES-HULETT, Arnaldo et al.Annals of allergy, asthma, & immunology. 2005, Vol 94, Num 1, pp 34-38, issn 1081-1206, 5 p.Article

Reduction of N-Hydroxy-sulfonamides, Including N-Hydroxy-valdecoxib, by the Molybdenum-Containing Enzyme mARCHAVEMEYER, Antje; GRUNEWALD, Sanja; WAHL, Bettina et al.Drug metabolism and disposition. 2010, Vol 38, Num 11, pp 1917-1921, issn 0090-9556, 5 p.Article

Valdecoxib is as efficacious as diclofenac in the treatment of acute low back painXIMENES, Antonio; ROBLES, Manuel; SANDS, George et al.The Clinical journal of pain. 2007, Vol 23, Num 3, pp 244-250, issn 0749-8047, 7 p.Article

Efficacy and safety of valdecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trialsEDWARDS, Jayne E; MCQUAY, Henry J; MOORE, R. Andrew et al.Pain (Amsterdam). 2004, Vol 111, Num 3, pp 286-296, issn 0304-3959, 11 p.Article

Valdecoxib: A reviewCHAVEZ, Mary L; DEKORTE, Carrie J.Clinical therapeutics. 2003, Vol 25, Num 3, pp 817-851, issn 0149-2918, 35 p.Article

How celecoxib could be safer, how valdecoxib might have beenCOHEN, Jay S.The Annals of pharmacotherapy. 2005, Vol 39, Num 9, pp 1542-1545, issn 1060-0280, 4 p.Article

The effect of mild and moderate hepatic impairment on the pharmacokinetics of valdecoxib, a selective COX-2 inhibitorSARAPA, Nenad; BRITTO, Margaret R; MAINKA, Michelle B et al.European journal of clinical pharmacology. 2005, Vol 61, Num 4, pp 247-256, issn 0031-6970, 10 p.Article

Iodocyclization of Hydroxylamine Derivatives Based on the Control of Oxidative Aromatization Leading to 2,5-Dihydroisoxazoles and IsoxazolesOKITSU, Takashi; SATO, Kana; POTEWAR, Taterao M et al.Journal of organic chemistry. 2011, Vol 76, Num 9, pp 3438-3449, issn 0022-3263, 12 p.Article

Solubility of valdecoxib in the presence of poly(ethylene glycol) 4000, poly(ethylene glycol) 6000, poly(ethylene glycol) 8000, and poly(ethylene glycol) 10 000 at (298.15, 303.15, and 308.15) KCHENGUANG LIU; DESAI, Kashappa Goud H; CHENGSHENG LIU et al.Journal of chemical and engineering data (Print). 2005, Vol 50, Num 1, pp 278-282, issn 0021-9568, 5 p.Article

Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxibGOLDSTEIN, J. L; EISEN, G. M; AGRAWAL, N et al.Alimentary pharmacology & therapeutics. 2004, Vol 20, Num 5, pp 527-538, issn 0269-2813, 12 p.Article

Cardiovascular Safety of the Cyclooxygenase-2 Selective Inhibitors Parecoxib and Valdecoxib in the Postoperative Setting : An Analysis of Integrated DataSCHUG, Stephan A; JOSHI, Girish P; CAMU, Frederic et al.Anesthesia and analgesia. 2009, Vol 108, Num 1, pp 299-307, issn 0003-2999, 9 p.Article

Safety and efficacy of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib after noncardiac surgeryNUSSMEIER, Nancy A; WHELTON, Andrew A; BROWN, Mark T et al.Anesthesiology (Philadelphia). 2006, Vol 104, Num 3, pp 518-526, issn 0003-3022, 9 p.Article

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgeryNUSSMEIER, Nancy A; WHELTON, Andrew A; BROWN, Mark T et al.The New England journal of medicine. 2005, Vol 352, Num 11, pp 1081-1091, issn 0028-4793, 11 p.Article

A Randomized Controlled Trial of Valdecoxib and Glyceryl Trinitrate for the Prevention of Post-ERCP PancreatitisBHATIA, Vikram; AHUJA, Vineet; SUBRAT KUMAR ACHARYA et al.Journal of clinical gastroenterology. 2011, Vol 45, Num 2, pp 170-176, issn 0192-0790, 7 p.Article

An effective dose of valdecoxib in experimental mouse models of painGUO, C. X. X; IRWIN, M. G; CHEUNG, K. M. C et al.Methods and findings in experimental and clinical pharmacology. 2007, Vol 29, Num 6, pp 383-388, issn 0379-0355, 6 p.Article

Effects of valdecoxib in the treatment of chronic low back pain: Results of a randomized, placebo-controlled trialCOATS, Teresa L; BORENSTEIN, David G; NANGIA, Narinder K et al.Clinical therapeutics. 2004, Vol 26, Num 8, pp 1249-1260, issn 0149-2918, 12 p.Article

Parecoxib and its metabolite valdecoxib directly interact with cannabinoid binding sites in CB1-expressing HEK 293 cells and rat brain tissueSCHRÖDER, Helmut; HÖLLT, Volker; BECKER, Axel et al.Neurochemistry international. 2011, Vol 58, Num 1, pp 9-13, issn 0197-0186, 5 p.Article

Enhancement of dissolution rate of valdecoxib using solid dispersions with polyethylene glycol 4000CHENGSHENG LIU; CHENGUANG LIU; DESAI, Kashappa Goud H et al.Drug development and industrial pharmacy. 2005, Vol 31, Num 1, pp 1-10, issn 0363-9045, 10 p.Article

Cyclooxygenase-2 inhibitorsGAJRAJ, Noor M.Anesthesia and analgesia. 2003, Vol 96, Num 6, pp 1720-1738, issn 0003-2999, 19 p.Article

  • Page / 4